Programme - All timings are Swedish time (CET). Exact timings and parts of agenda may be subject to change
13.00	Workshop introduction
13.15	In vitro systems for mechanistic evaluation of drug-drug interactionrisk associated with peptide analogues  Carolina Säll/Deepak Kumar Bhatt, Novo Nordisk
13.50	The impact of septic shock on the phamacokinetics and pharmacodynamics of selepressin Daniel Jonker, Ferring
14.25	MS processing software for peptide met-ID (working title) Jan Boerma, UniLabs
15.00	Break
15.20	Peptide drug metabolism profiling in preclinical drug development  Simon Hauri, Roche
15.55	A company strategy for immunogenicity testing of peptide drugs Birgitte Buur Rasmussen, Ferring
16.30	Automated LC-MS based in vitro assay to asses protease stability of pharmacologically active peptides for inhalation Frank Wesche, AZ
17.05 - 17.40	Free session discussion/meeting roundup